Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Lambert-Eaton Syndrome

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Superficial anterior muscles
Superficial anterior muscles

Alternative Names    Return to top

Myasthenic syndrome; Eaton-Lambert syndrome

Definition    Return to top

Lambert-Eaton syndrome is characterized by muscle weakness that improves with continued contraction of the muscle.

Causes    Return to top

Lambert-Eaton syndrome (myasthenic syndrome) is a disorder with symptoms very similar to those of myasthenia gravis. There is muscle weakness associated with disturbed communication between nerves and muscles.

In myasthenia gravis, the neurotransmitter acetylcholine (the chemical that transmits impulses between nerves and muscles) is blocked by antibodies to its receptor.

In Lambert-Eaton syndrome, however, the signal distortion is caused by an insufficient release of neurotransmitter by the nerve cell. As muscle contraction is continued, the amount of neurotransmitter may build up in sufficient quantities and result in increased strength.

The disorder may be associated with small-cell carcinoma of the lung and other malignancies as a paraneoplastic syndrome or with autoimmune disorders.

Symptoms    Return to top

Additional symptoms that may be associated with this disease:

Exams and Tests    Return to top

An examination shows weakness or paralysis that improves with activity. Reflexes may be decreased. There may be muscle atrophy (loss of muscle tissue).

A Tensilon test can be positive. A baseline muscle-strength evaluation is performed. After Tensilon (edrophonium) or other short-acting neurotransmitter is given, there may be a noticeable improvement of function.

EMG and nerve conduction velocity tests may confirm the diagnosis, with improved function as contraction is prolonged or with repetitive stimulation.

Treatment    Return to top

The primary goal of treatment is to identify and treat any tumors or other underlying disorders. Plasmapheresis, where blood plasma is removed and replaced with fluid, may improve symptoms.

Prednisone or other medications that suppress the immune response may improve symptoms in some cases. Medications can also include anticholinesterase medications such as Neostigmine or Pyridostigmine. 3, 4-diaminopyridine is a medicine that increases acetylcholine release from the nerves and helps keep the electrical nerve action working for longer.

Outlook (Prognosis)    Return to top

An important factor is whether there is an underlying tumor that can be treated. The symptoms of Lambert-Eaton syndrome may improve with treatment of the tumor and/or with suppressing the immune system. However, not all people respond well to treatment.

Possible Complications    Return to top

When to Contact a Medical Professional    Return to top

Call your health care provider if symptoms of this condition develop.

Update Date: 8/7/2006

Updated by: Daniel Kantor, M.D., Director of the Comprehensive MS Center, Neuroscience Institute, University of Florida Health Science Center, Jacksonville, FL. Review provided by VeriMed Healthcare Network.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2008, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.